HK181596A - Preparation to prevent adhesion of organs and organ parts - Google Patents

Preparation to prevent adhesion of organs and organ parts Download PDF

Info

Publication number
HK181596A
HK181596A HK181596A HK181596A HK181596A HK 181596 A HK181596 A HK 181596A HK 181596 A HK181596 A HK 181596A HK 181596 A HK181596 A HK 181596A HK 181596 A HK181596 A HK 181596A
Authority
HK
Hong Kong
Prior art keywords
poly
polypropylene
organs
hydroxyethylcellulose
patients
Prior art date
Application number
HK181596A
Other languages
German (de)
English (en)
French (fr)
Inventor
Helmut Dr. Franz
Thomas Dr. Dipl.-Chem. Mueller
Wolfgang Prof. Dr. Dr. Dr. Eisert
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of HK181596A publication Critical patent/HK181596A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK181596A 1987-12-04 1996-09-26 Preparation to prevent adhesion of organs and organ parts HK181596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873741149 DE3741149A1 (de) 1987-12-04 1987-12-04 Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen

Publications (1)

Publication Number Publication Date
HK181596A true HK181596A (en) 1996-10-04

Family

ID=6341894

Family Applications (1)

Application Number Title Priority Date Filing Date
HK181596A HK181596A (en) 1987-12-04 1996-09-26 Preparation to prevent adhesion of organs and organ parts

Country Status (18)

Country Link
US (1) US5578305A (el)
EP (1) EP0318801B1 (el)
JP (1) JP2741767B2 (el)
KR (1) KR970010545B1 (el)
AT (1) ATE67678T1 (el)
AU (1) AU622632B2 (el)
CA (1) CA1330298C (el)
DE (2) DE3741149A1 (el)
DK (1) DK167049B1 (el)
ES (1) ES2037803T3 (el)
GR (1) GR3003156T3 (el)
HK (1) HK181596A (el)
HU (1) HU201476B (el)
IE (1) IE61464B1 (el)
IL (1) IL88564A (el)
NZ (1) NZ227183A (el)
PH (1) PH31058A (el)
ZA (1) ZA889048B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
EP0887076A3 (en) 1997-05-07 1999-03-31 Saturnus A.G. Adhesion prevention and an endoscopic insufflation system therefor
WO2004039415A2 (en) 2002-10-28 2004-05-13 Northgate Technologies Inc. Dual-capacity insufflator tube
US7654975B2 (en) * 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
ES2336796T3 (es) * 2003-10-07 2010-04-16 Northgate Technologies Incorporated Sistema para suministrar una sustancia a una cavitacion corporal.
CA2771129C (en) 2003-10-31 2015-09-29 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
CA2989941A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compostions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
CA2660050A1 (en) 2006-08-04 2008-02-07 Northgate Technologies Inc. In-dwelling port for access into a body
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
GR79202B (el) * 1982-05-05 1984-10-22 Genentech Inc
JPS59501159A (ja) * 1982-06-24 1984-07-05 スミス、ロバ−ト・アラン 薬用ゲル組成物
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
KR870005646A (ko) * 1985-12-16 1987-07-06 로버트 엘. 미니어 수술후 유착형성 억제방법
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
KR0131330B1 (ko) * 1987-07-01 1998-04-17 맥스 디. 헨슬레이 피브린 침착 또는 유착을 방지하기 위한 방법 및 치료 조성물
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader

Also Published As

Publication number Publication date
IE61464B1 (en) 1994-11-02
PH31058A (en) 1998-02-05
KR970010545B1 (ko) 1997-06-28
EP0318801A2 (de) 1989-06-07
US5578305A (en) 1996-11-26
NZ227183A (en) 1991-07-26
DE3741149A1 (de) 1989-06-15
ES2037803T3 (es) 1993-07-01
EP0318801B1 (de) 1991-09-25
JP2741767B2 (ja) 1998-04-22
ZA889048B (en) 1990-08-29
ATE67678T1 (de) 1991-10-15
DE3865182D1 (el) 1991-10-31
AU2648588A (en) 1989-06-08
CA1330298C (en) 1994-06-21
DK672488D0 (da) 1988-12-02
DK672488A (da) 1989-06-05
IL88564A (en) 1994-12-29
HU201476B (en) 1990-11-28
IE883608L (en) 1989-06-04
GR3003156T3 (en) 1993-02-17
HUT49289A (en) 1989-09-28
EP0318801A3 (en) 1989-08-09
IL88564A0 (en) 1989-07-31
KR890009408A (ko) 1989-08-01
DK167049B1 (da) 1993-08-23
JPH01193230A (ja) 1989-08-03
AU622632B2 (en) 1992-04-16

Similar Documents

Publication Publication Date Title
US5364622A (en) Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
US5691312A (en) Pharmaceutical for subcutaneous or intramuscular administration containing polypeptides
HK181596A (en) Preparation to prevent adhesion of organs and organ parts
JP2010529997A (ja) 安定化トロンビン組成物
EP1459738A1 (en) Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
JP2024056090A (ja) 組織癒着を防止するための低濃縮タンパク質組成物
US20030091558A1 (en) Storage-stable fibrinogen solutions
EP0297860B1 (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
EP0438234A1 (en) Antithrombin solution and use thereof
JPH08253425A (ja) 傷治癒を改善するプラスミノーゲン活性化因子からなる製剤の使用
US20030091559A1 (en) Storage-stable human fibrinogen solutions
EP3569636A1 (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
JP2526073B2 (ja) 異常破水治療剤
NZ618882B2 (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20081121